Related references
Note: Only part of the references are listed.A-G-4G haplotype of PAI-1 gene polymorphisms-844 G/A, HindIII G/C, and-675 4G/5G is associated with increased risk of ischemic stroke caused by small vessel disease
M. G. Adamski et al.
ACTA NEUROLOGICA SCANDINAVICA (2009)
Prothrombotic polymorphisms, mutations, and their association with pediatric non-cardioembolic stroke in Asian-Indian patients
Arijit Biswas et al.
ANNALS OF HEMATOLOGY (2009)
Sequence Variants on Chromosome 9p21.3 Confer Risk for Atherosclerotic Stroke
Andreas Gschwendtner et al.
ANNALS OF NEUROLOGY (2009)
The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke
Ferdinand Miteff et al.
BRAIN (2009)
Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients
Raf Brouns et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2009)
Potential Applications of Hydrogen Sulfide-Induced Suspended Animation
Hamid Aslami et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins
Fabrizio Semeraro et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaernic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial
Erich Bluhmki et al.
LANCET NEUROLOGY (2009)
Incretin-based therapies for type 2 diabetes mellitus
Julie A. Lovshin et al.
NATURE REVIEWS ENDOCRINOLOGY (2009)
Experience-dependent structural synaptic plasticity in the mammalian brain
Anthony Holtmaat et al.
NATURE REVIEWS NEUROSCIENCE (2009)
Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006
Y. Bejot et al.
NEUROLOGY (2009)
BRAIN-IMMUNE INTERACTIONS IN ACUTE AND CHRONIC BRAIN DISORDERS INTRODUCTION
U. Dirnagl et al.
NEUROSCIENCE (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Good Laboratory Practice Preventing Introduction of Bias at the Bench
Malcolm R. Macleod et al.
STROKE (2009)
Defeating Normal Thermoregulatory Defenses Induction of Therapeutic Hypothermia
Daniel I. Sessler
STROKE (2009)
The penumbra system: A mechanical device for the treatment of acute stroke due to thromboembolism
A. Bose et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis
T. Kuhlmann et al.
BRAIN (2008)
Susceptibility loci for intracranial aneurysm in European and Japanese populations
Kaya Bilguvar et al.
NATURE GENETICS (2008)
Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke
Enming J. Su et al.
NATURE MEDICINE (2008)
A new penumbra: transitioning from injury into repair after stroke
Eng H. Lo
NATURE MEDICINE (2008)
Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart
Harald C. Ott et al.
NATURE MEDICINE (2008)
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
Werner Hacke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Adherent Self-Renewable Human Embryonic Stem Cell-Derived Neural Stem Cell Line: Functional Engraftment in Experimental Stroke Model
Marcel M. Daadi et al.
PLOS ONE (2008)
Meta-analysis of the efficacy of granulocyte-colony stimulating factor in animal models of focal cerebral ischemia
Jens Minnerup et al.
STROKE (2008)
Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis
H. Bart van der Worp et al.
BRAIN (2007)
Normobaric hyperoxia mismatch evolution, delays perfusion/diffusion infarct volume, and differentially affects neuronal cell death pathways after suture middle cerebral artery occlusion in rats
Nils Henninger et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Improgan-induced hypothermia: A role for cannabinoid receptors in improgan-induced changes in nociceptive threshold and body temperature
Catherine L. Salussolia et al.
BRAIN RESEARCH (2007)
Progenitor cells and adult neurogenesis in neurodegenerative diseases and injuries of the basal ganglia
Maurice A. Curtis et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Thrombin activatable fibrinolysis inhibitor activation peptide shows association with all major subtypes of ischemic stroke and with TAFI gene variation
Claes Ladenvall et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Is exogenous tissue plasminogen activator necessary for antithrombotic efficacy of an inhibitor of thrombin activatable fibrinolysis inhibitor (TAFI) in rats?
Eileen Bird et al.
THROMBOSIS RESEARCH (2007)
How can we improve the pre-clinical development of drugs for stroke?
Emily Sena et al.
TRENDS IN NEUROSCIENCES (2007)
Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials
Katayoun Vahedi et al.
LANCET NEUROLOGY (2007)
Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior anti hypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122)
D. Thomas et al.
INTERNATIONAL JOURNAL OF STROKE (2006)
NXY-059 for acute ischemic stroke
KR Lees et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
Hans-Christoph Diener
INTERNATIONAL JOURNAL OF STROKE (2006)
CADASIL: A critical look at a Notch disease
A Louvi et al.
DEVELOPMENTAL NEUROSCIENCE (2006)
Safety and efficacy of mechanical embolectomy in acute ischemic stroke - Results of the MERCI trial
WS Smith et al.
STROKE (2005)
A pilot study of normobaric oxygen therapy in acute ischemic stroke
AB Singhal et al.
STROKE (2005)
Recombinant activated factor VII for acute intracerebral hemorrhage
SA Mayer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Stroke units, tissue plasminogen activator, aspirin and neuroprotection: Which stroke intervention could provide the greatest community benefit?
AK Gilligan et al.
CEREBROVASCULAR DISEASES (2005)
Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol - The Losartan Intervention for Endpoint reduction in hypertension study
JR Kizer et al.
HYPERTENSION (2005)
The Desmoteplase In Acute Ischemic Stroke Trial (DIAS) - A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase
W Hacke et al.
STROKE (2005)
Pathophysiology of stroke: Lessons from animal models
P Mergenthaler et al.
METABOLIC BRAIN DISEASE (2004)
Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke
AV Alexandrov et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Protected carotid-artery stenting versus endarterectomy in high-risk patients
JS Yadav et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Annual incidence of first silent stroke in the United States: A preliminary estimate
MC Leary et al.
CEREBROVASCULAR DISEASES (2003)
Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century
VL Feigin et al.
LANCET NEUROLOGY (2003)
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack (Vol 358, pg 1033, 2001)
LANCET (2001)
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
S MacMahon et al.
LANCET (2001)
Brain plasticity and stroke rehabilitation - The Willis Lecture
BB Johansson
STROKE (2000)
Share Paper
